Author Question: In the context of theuse of factorial designs to study external validity, an_____ indicates thatthe ... (Read 111 times)

anshika

  • Hero Member
  • *****
  • Posts: 510
In the context of theuse of factorial designs to study external validity, an_____ indicates thatthe levels of the independent variableinteractwit h the personvariable to producedifferent outcomes.
 
  a. intervention effect
  b. interaction effect
  c. interrelation effect
  d. interdependence effect

Question 2

In solution-based counseling, __________ are viewed as intimately connected with a client's context, but are not considered curative.
 
  a. solutions
  b. emotions
  c. strengths
  d. problems



helenmarkerine

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

b

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

anshika

  • Hero Member
  • *****
  • Posts: 510
Both answers were spot on, thank you once again




 

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library